Pull 4 Parkinson’s Foundation, Inc., a registered 501(c)(3) public charity,
funds cure and care research conducted by the Parkinson's disease community.
Learn More or Donate.

Burning mouth syndrome in Parkinson’s disease: dopamine as cure or cause?

Neuromuscular Division, Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA, coon.elizabeth@mayo.edu

Abstract

Burning mouth syndrome has been reported as being more common in Parkinson's disease patients than the general population. While the pathophysiology is unclear, decreased dopamine levels and dopamine dysregulation are hypothesized to play a role. We report a patient with Parkinson's disease who developed burning mouth syndrome with carbidopa/levodopa. Our patient had resolution of burning mouth symptoms when carbidopa/levodopa was replaced with a dopamine agonist. Based on our patient's clinical course, in conjunction with earlier studies assessing the relationship between burning mouth syndrome and Parkinson's disease, we discuss a potential role for dopamine in burning mouth syndrome in Parkinson's disease.

PMID: 22322657
[PubMed - indexed for MEDLINE]

PMCID: PMC3311832

 

Comments

Article’s News Categories:

Related Articles: